A randomized, parallel-group, double-blind, placebo-cont

Project: Research project

Project Details

Description

A randomized, parallel-group, double-blind, placebo-controlled, multi-center study of Eculizumab for the prevention of delayed graft function after kidney transplantation in adult subjects at increased risk of delayed graft function
StatusFinished
Effective start/end date5/20/146/1/19

Funding

  • ALEXION PHARMACEUTICALS

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.